Genesis HealthCare Announces Resident and Staff COVID-19 Vaccine Acceptance Rates
February 02 2021 - 6:36PM
Genesis HealthCare, (“Genesis” or “Company”) (NYSE: GEN), one of
the largest post-acute care providers in the United States,
announced today that 84% of its skilled nursing residents and 61%
of skilled nursing staff members have been vaccinated, each
receiving their first dose of the COVID-19 vaccine, through
January 29, 2021. Staff vaccine acceptance rates far exceed the
national average, and resident acceptance rates at Genesis skilled
nursing centers were also above the national average, based on
vaccine administration data in an analysis published by the Centers
for Disease Control and Prevention (CDC).
On February 1, 2021, the CDC announced that “among 11,460 SNFs
with at least one vaccination clinic conducted during the first
month of the CDC Pharmacy Partnership for Long-Term Care Program, a
median of 77.8% of residents and 37.5% of staff members received ≥1
vaccine dose through the program.”
“I am so extraordinarily proud of the progress our centers have
made vaccinating both residents and staff,” states Dr. Richard
Feifer, Chief Medical Officer of Genesis. “Our leadership team,
clinicians, physicians and advanced practice providers have been
working around the clock to educate patients, residents, staff and
families about the importance of being vaccinated, and to answer
every point of hesitancy or concern with a combination of
compassion and factual information. These acceptance rates are a
testament to the hard work and dedication our leadership and center
staff have shown throughout this entire pandemic. We are not done
yet, and continue our work to increase vaccination rates even
higher.”
As of January 21, 2021, 100% of Genesis skilled nursing
facilities received dose one of the vaccine, primarily utilizing
CVS Health, our primary partner through the Pharmacy Partnership
for Long Term Care program. Genesis facilities were among the first
to begin vaccinations in nursing homes, beginning on December 17,
2020. After the first clinic, the pharmacists return three to four
weeks later to administer the second booster shots for those who
received the vaccine in round one, and will also vaccinate anyone
not included in round one. The pharmacists will then return for a
third time, three to four weeks after round two, to administer the
final booster shots. Genesis skilled nursing facilities are
approximately 67% through their second clinics.
Genesis continues its robust communications and engagement
initiatives to build trust among patients, residents, families and
staff. Genesis has conducted ‘Ask the Doc’ sessions, social media
campaigns, educational outreach, and a variety of other engagement
tactics to promote vaccination. Multiple second clinics are ongoing
every day and Genesis facilities are striving to get as many people
vaccinated as quickly as possible at each clinic. The Company
expects acceptance rates to continue to climb.
All drugs or vaccines have some potential side effects, and it
is important to monitor for such issues even after a drug or
vaccine is approved. Thus far, there have been minimal reported
side effects after patients, residents and staff have received the
vaccine. As the largest nursing home operator, Genesis is
participating in a newly developed safety monitoring program with
Brown University School of Public Health researchers, to monitor
for any potential adverse health impacts after nursing home
residents in our centers receive COVID-19 vaccinations. This work
is part of a CDC effort to carefully monitor vaccine safety,
particularly focused on frail elderly residents who were not
included in vaccine trials.
About Genesis HealthCareGenesis HealthCare is a
holding company with subsidiaries that, on a combined basis,
comprise one of the nation's largest post-acute care companies,
providing services to more than 325 skilled nursing facilities and
assisted/senior living communities in 24 states nationwide. Genesis
subsidiaries also supply rehabilitation therapy to approximately
1,100 healthcare providers in 44 states, the District of Columbia
and China. References made in this release to "Genesis," "the
Company," "we," "us" and "our" refer to Genesis Healthcare, Inc.
and each of its wholly-owned companies. Visit our website at
www.genesishcc.com.
Media
Contact: |
Lori
Mayer |
|
610-283-4995 |
Genesis Healthcare (NYSE:GEN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Genesis Healthcare (NYSE:GEN)
Historical Stock Chart
From Sep 2023 to Sep 2024